Alkanon DT-1000 Dispersible Dispersible Tablet

About Alkanon DT-1000 Dispersible 1 gm Dispersible Tablet

Alkanon DT-1000 Dispersible is a dispersible tablet containing nabumetone, a non-steroidal anti-inflammatory medicine (NSAID). It is made by Renata PLC and is used in adults for arthritis-related pain and swelling, with the dose set by the doctor.

There are 28 brands of Nabumetone listed in Bangladesh. The lowest listed price is Relanab 500 mg Tablet at ৳ 15 per unit.

What is Alkanon DT-1000 Dispersible 1 gm Dispersible Tablet?

Nabumetone belongs to a group of medicines called non-steroidal anti-inflammatory drugs, often shortened to NSAIDs. It works in the body by blocking the enzymes that help make prostaglandins, which are substances involved in pain, swelling and fever. In the body, nabumetone is converted into its active form. Alkanon DT-1000 Dispersible is supplied as a 1 gm dispersible tablet by Renata PLC. Dispersible means the tablet is made to be mixed with water before taking. It is used for the signs and symptoms of osteoarthritis and rheumatoid arthritis. Whether it suits a particular person, and for how long, is decided by the doctor.

Uses of Alkanon DT-1000 Dispersible

Alkanon DT-1000 Dispersible is used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis in adults. Osteoarthritis and rheumatoid arthritis can cause joint pain, stiffness and swelling, and this medicine is intended to ease those symptoms. It does not reverse joint damage. Before starting it, the doctor weighs the possible benefits against the possible risks and considers other treatment options. The doctor also decides how long it should be taken.

How to use Alkanon DT-1000 Dispersible

A dispersible tablet is made to be dispersed in water before it is taken. Follow the doctor's instructions on how to prepare and take it, and whether to take it with or without food. Swallow or take it exactly as directed. The doctor sets the dose and the length of the course, and may adjust the dose after seeing how you respond. Do not change the dose or stop on your own. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Alkanon DT-1000 Dispersible

Stomach and bowel problems are among the more common side effects, including diarrhoea, indigestion, abdominal pain, constipation, wind, nausea, vomiting, dry mouth, inflammation of the stomach lining and mouth sores. Some people notice dizziness, headache, tiredness, sweating, trouble sleeping, nervousness or drowsiness. Itching, rash, ringing in the ears and swelling may also occur. Tell your doctor about any side effect that bothers you or does not go away. Seek medical help at once for severe stomach pain, black stools, vomiting blood, breathing problems or swelling of the face.

Safety and precautions

Do not take Alkanon DT-1000 Dispersible if you have had an allergic reaction to nabumetone or any of its ingredients, or if you have had asthma, hives or allergic-type reactions after aspirin or another NSAID. It is not for pain relief around coronary artery bypass graft surgery. Tell your doctor about all other medicines you take, including ACE inhibitors for blood pressure. In pregnancy, it should be used only if the doctor decides the benefit justifies the risk; there are no adequate studies in pregnant women. It is not known whether it passes into human breast milk, so discuss breastfeeding with your doctor. Ask your doctor first if you have kidney, liver, heart or stomach problems, or if you take corticosteroids.

Frequently asked questions

What does the generic name nabumetone mean?

Nabumetone is the generic name of the active ingredient in Alkanon DT-1000 Dispersible. It is a naphthylalkanone and a non-steroidal anti-inflammatory drug, or NSAID. In the body it is converted into its active form, which blocks the enzymes involved in making prostaglandins, substances linked to pain and swelling.

What is Alkanon DT-1000 Dispersible used for, and what kind of medicine is it?

It is an NSAID used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis. It is a dispersible tablet that is mixed with water before taking. The doctor decides whether it is suitable for you, the dose and how long you should take it.

What side effects should I watch for, and when should I call the doctor?

Watch for diarrhoea, indigestion, stomach pain, nausea, dizziness, headache or rash. Call your doctor if a side effect bothers you or does not settle. Get medical help straight away for severe stomach pain, black stools, vomiting blood, breathing difficulty or swelling of the face.

Can I stop taking it on my own or change the dose?

No. The doctor decides the dose and the length of the course, and may adjust it after seeing how you respond. Do not change the dose or stop on your own. If you have questions about how to take it or want to stop, speak to your doctor or pharmacist first.

Indications

Nabumetone is indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. Carefully consider the potential benefits and risks of Nabumetone and other treatment options before deciding to use Nabumetone. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals

Pharmacology

Nabumetone is a naphthylalkanone. Is is a non-selective prostaglandin G/H synthase (a.k.a. cyclooxygenase or COX) inhibitor that acts on both prostaglandin G/H synthase 1 and 2 (COX-1 and -2). Prostaglandin G/H synthase catalyzes the conversion of arachidonic acid to prostaglandin G2 and prostaglandin G2 to prostaglandin H2. Prostaglandin H2 is the precursor to a number of prostaglandins involved in fever, pain, swelling, inflammation, and platelet aggregation. The parent compound is a prodrug that undergoes hepatic biotransformation to the active compound, 6-methoxy-2-naphthylacetic acid (6MNA). The analgesic, antipyretic and anti-inflammatory effects of NSAIDs occur as a result of decreased prostaglandin synthesis.

The parent compound is a prodrug, which undergoes hepatic biotransformation to the active component, 6-methoxy-2-naphthylacetic acid (6MNA), that is a potent inhibitor of prostaglandin synthesis, most likely through binding to the COX-2 and COX-1 receptors.

Dosage & Administration

Osteoarthritis and Rheumatoid Arthritis: The recommended starting dose is 1,000 mg taken as a single dose with or without food. Some patients may obtain more symptomatic relief from 1,500 mg to 2,000 mg per day. Nabumetone can be given in either a single or twice-daily dose. Dosages greater than 2,000 mg per day have not been studied. The lowest effective dose should be used for chronic treatment.  Patients weighing under 50 kg may be less likely to require dosages beyond 1,000 mg; therefore, after observing the response to initial therapy, the dose should be adjusted to meet individual patients’ requirements.

Interaction

Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors.

Contraindications

Nabumetone is contraindicated in patients with known hypersensitivity to nabumetone or its excipients. Nabumetone should not be given to patients who have experienced asthma, urticaria, or allergictype reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Nabumetone is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery

Side Effects

Gastrointestinal: Diarrhea (14%), dyspepsia (13%), abdominal pain (12%), constipation, flatulence, nausea, positive stool guaiac, dry mouth, gastritis, stomatitis, vomiting.

Central Nervous System: Dizziness, headache, fatigue, increased sweating, insomnia, nervousness, somnolence.

Dermatologic: Pruritus, rash

Special Senses: Tinnitus

Miscellaneous: Edema

Pregnancy & Lactation

Pregnancy Category C. Reproductive studies conducted in rats and rabbits have not demonstrated evidence of developmental abnormalities. However, animal reproduction studies are not always predictive of human response. There are no adequate, well-controlled studies in pregnant women. Nabumetone should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.

Nursing Mothers: It is not known whether this drug is excreted in human milk, however 6MNA is excreted in the milk of lactating rats. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Nabumetone, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Labor and Delivery: In rat studies with NSAIDs, as with other drugs known to inhibit prostaglandin synthesis, an increased incidence of dystocia, delayed parturition, and decreased pup survival occurred. The effects of Nabumetone on labor and delivery in pregnant women are unknown.

Precautions & Warnings

Nabumetone cannot be expected to substitute for corticosteroids or to treat corticosteroid insufficiency. Abrupt discontinuation of corticosteroids may lead to disease exacerbation. Patients on prolonged corticosteroid therapy should have their therapy tapered slowly if a decision is made to discontinue corticosteroids. The pharmacological activity of Nabumetone in reducing fever and inflammation may diminish the utility of these diagnostic signs in detecting complications of presumed noninfectious, painful conditions

Overdose Effects

Symptoms following acute NSAIDs overdoses are usually limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding can occur. Hypertension, acute renal failure, respiratory depression, and coma may occur, but are rare. Anaphylactoid reactions have been reported with therapeutic ingestion of NSAIDs, and may occur following an overdose.

Patients should be managed by symptomatic and supportive care following a NSAIDs overdose. There are no specific antidotes. Emesis and/or activated charcoal (60 to 100 grams in adults, 1 to 2 g/kg in children), and/or osmotic cathartic may be indicated in patients seen within 4 hours of ingestion with symptoms or following a large overdose (5 to 10 times the usual dose). Forced diuresis, alkalinization of urine, hemodialysis, or hemoperfusion may not be useful due to high protein binding.

There have been overdoses of up to 25 grams of Nabumetone reported with no long-term sequelae following standard emergency treatment (i.e., activated charcoal, gastric lavage, IV H2-blockers, etc.).

Storage Conditions

Store at 25°C; excursions permitted to 15-30°C in well-closed container; dispense in light-resistant container.

Alternative brands of Nabumetone

Other brands with the same generic name, cheapest first.

Aponia Tablet

500 mg

Nabumetone

One Pharma Ltd.

৳ 14.7 ৳ 15.00 2% off per unit

Buflex Tablet

500 mg

Nabumetone

Beximco Pharmaceuticals Ltd.

৳ 14.7 ৳ 15.00 2% off per unit

Alkanon Tablet

750 mg

Nabumetone

Renata Limited

৳ 21.56 ৳ 22.00 2% off per unit

Aponia Tablet

750 mg

Nabumetone

One Pharma Ltd.

৳ 21.56 ৳ 22.00 2% off per unit

Buflex Tablet

750 mg

Nabumetone

Beximco Pharmaceuticals Ltd.

৳ 21.56 ৳ 22.00 2% off per unit

Aponia Tablet

1000 mg

Nabumetone

One Pharma Ltd.

৳ 27.44 ৳ 28.00 2% off per unit

Buflex Tablet

1000 mg

Nabumetone

Beximco Pharmaceuticals Ltd.

৳ 29.4 ৳ 30.00 2% off per unit

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.